Ulipristal Acetate for Cervical Preparation

Completed · Early Phase 1

Conditions studied: Termination of Pregnancy

In brief

This is a prospective cohort study exploring a broadened use of ulipristal acetate as a cervical preparation agent for second trimester surgical abortion. Specifically, this pilot study will test the feasibility of using ulipristal as a pharmacologic cervical preparation with adjunct misoprostol prior to surgical abortion.

Key facts

Study ID
NCT03802149
Run by
Stanford University
People needed
13
Starts
2019-04-16
Expected to finish
2020-04-02
Last updated by the study team
2020-07-01

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.